Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug
Go back to Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug| (NASDAQ: QNRX) | Delayed: 5.57 +0.58 (11.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.99 | 52 Week High | $ | |||
| Open | $5.29 | 52 Week Low | $ | |||
| Day High | $5.88 | P/E | N/A | |||
| Day Low | $5.02 | EPS | $ | |||
| Volume | 72,107 | |||||

